TABLE 5.
Causative microorganisms isolated from 71 patients and bacteriological result by pathogen
| Organism | No. (%) of patients
|
|||
|---|---|---|---|---|
| Ciprofloxacin
|
Ceftazidime plus amikacin
|
|||
| Eradication | Persistence | Eradication | Persistence | |
| Gram-positive bacteria | ||||
| Staphylococcus epidermidis | 4 | 1 | 6 | 3 |
| Staphylococcus aureus | 1 | 2 | ||
| Staphylococcus saprophyticus | 1 | |||
| Staphylococcus warneri | 1 | |||
| Streptococcus pneumoniae | 1 | 1 | ||
| Viridans group streptococci | 3 | 2 | 1 | 1 |
| Streptococcus sanguis | 1 | |||
| Streptococcus spp. | 1 | |||
| Enterococcus faecalis | 1 | 2 | ||
| Enterococcus spp. | 1 | |||
| Others | 1 | |||
| Subtotal | 10 (66.7) | 5 (33.3) | 15 (75) | 5 (25) |
| Gram-negative bacteria | ||||
| Escherichia coli | 6 | 1 | 11 | |
| Klebsiella pneumoniae | 4 | 1 | ||
| Klebsiella oxytoca | 1 | |||
| Pseudomonas aeruginosa | 7 | 3 | ||
| Enterobacter cloacae | 2 | 1 | ||
| Citrobacter diversus | 1 | |||
| Vibrio metschnikovii | 1 | |||
| Capnocytophaga spp. | 1 | |||
| Subtotal | 21 (95.5) | 1 (4.5) | 18 (100) | |
| Total | 31 (83.8) | 6 (16.2) | 33 (86.9) | 5 (13.1) |